:: Volume 21, Number 5 (9-2017) ::
IBJ 2017, 21(5): 312-320 Back to browse issues page
Accuracy of Soluble Endoglin for Diagnosis of Preeclampsia and its Severity
Pooneh Nikuei , Minoo Rajaei, Kianoosh Malekzadeh, Azim Nejatizadeh, Fatemeh Mohseni, Ali AtashAbParvar

Background: The use of biomarkers for diagnosis of Preeclampsia (PE), a life-threatening pregnancy disorder, could reduce serious complications of this disease. In this study, we investigated dysregulation of endoglin (Eng) expression and diagnostic accuracy of soluble endoglin (sEng) in PE patients. Methods: For this case-control study, 26 mild and 15 severe preeclamptic women along with 20 normotensive controls were recruited. The expression level of Eng (the co-receptor TGF-β1) was evaluated using qRT-PCR. Also, the serum concentration of soluble Eng and expression of membranous Eng were determined by ELISA and immunohistochemistry. Results:  A significant up-regulation in Eng mRNA and sEng levels was observed in PE patients versus normal controls. Immunohistochemistry (IHC) showed up-regulation of membranous Eng staining in syncytiotrophoblast and cytotrophoblast cells of PE patients. The serum levels of sEng were significantly increased in all patients (mild, sever, early- and late-onset) as compared to healthy pregnant women (P˂0.001). Receiver-operating characteristic (ROC) curve analysis revealed that sEng had the highest accuracy in distinguishing PE from normal pregnancies with cut-off value of 20.4, sensitivity of 92.1%, specificity of 90%, and area under the curve (AUC) of 0.94 (95% CI: 0.88-1.00). Conclusions: Our data showed that the up-regulation of Eng mRNA along with its membranous and soluble form in PE patients leads to defect in angiogenesis pathway. Also, the results of this study revealed sEng potential as a marker for diagnosis of PE and its severity.

Keywords: Preeclampsia, Endoglin, Biomarkers, Pregnancy
Full-Text [PDF 1179 kb]      
Type of Study: Full Length | Subject: Molecular Genetics & Genomics
Add your comments about this article
Your username or email:

Write the security code in the box >

DOI: 10.18869/acadpub.ibj.21.5.312
PMID: 28558439

XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nikuei P, Rajaei M, Malekzadeh K, Nejatizadeh A, Mohseni F, AtashAbParvar A. Accuracy of Soluble Endoglin for Diagnosis of Preeclampsia and its Severity. IBJ. 2017; 21 (5) :312-320
URL: http://ibj.pasteur.ac.ir/article-1-2063-en.html
Volume 21, Number 5 (9-2017) Back to browse issues page
Persian site map - English site map - Created in 0.173 seconds with 872 queries by yektaweb 3455